GlaxoSmithKline
GlaxoSmithKline/ News/ News/ R&D/ Top pharmaceutical companies/ Top stories
GSK signs $300m R&D deal with 23andMe
GlaxoSmithKline/ News/ Top pharmaceutical companies/ UK & Europe/ US
GSK could split amid pressure from investors – report
GSK’s blockbuster HIV drug linked with birth defects
Richard Staines
GlaxoSmithKline, HIV, safety, ViiV
0 Comment
Regulators issue warning after preliminary study findings
GlaxoSmithKline/ News/ UK & Europe
FDA approves expanded use for GSK’s COPD triple therapy
Richard Staines
COPD, GlaxoSmithKline, respiratory
0 Comment
GSK is aiming to revive its respiratory drugs franchise
GSK to pay $13bn for Novartis stake in OTC joint venture
Richard Staines
GlaxoSmithKline, M&A, Novartis, OTC
0 Comment
GlaxoSmithKline/ Market Access/ News/ News/ News/ R&D/ R&D/ UK & Europe
Verona to take COPD hopeful into phase 3
Richard Staines
Chiesi, COPD, GlaxoSmithKline, R&D, respiratory
0 Comment